| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Donald E Saunders last filed a Form 4 in May 2022, as Director at CHE. Donald E Saunders's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Donald E Saunders's trades have earned a middling insider score of 57/100 across 3 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +0.2%.
At the last filing, the largest reported position was 5,593 shares of CHE. The CHE filings lean toward selling, a net 8,869 shares.
Donald E Saunders has 30 Form 4 filings on record from May 2015 to May 2022, all as Director at Chemed (CHE), 2015–2022.
The 43 reported transactions were 31 open-market sales, 8 stock awards and 4 open-market purchases.
Counted by filing, the open-market trades come to 4 purchases worth about $65K and 22 sales worth about $2.9M.
The largest open-market purchase was 49 shares of CHE at an average $431.60 on May 11, 2020, about $21K.
The largest open-market sale was 510 shares of CHE at an average $526.45 on December 18, 2020, about $268K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2022 | CHE Chemed Corp | Director | Sell | 405 | $521.23 | $211,098.15 | -7.1% | -7.8% | +5.2% | |
| Dec 27, 2021 | CHE Chemed Corp | Director | Sell | 500 | $532.43 | $266,212.97 | -8.1% | -9.2% | -4.0% | |
| Nov 17, 2021 | CHE Chemed Corp | Director | Sell | 300 | $505.30 | $151,590.00 | -4.6% | -5.3% | -1.6% | |
| Dec 18, 2020 | CHE Chemed Corp | Director | Sell | 510 | $526.45 | $268,489.50 | -7.6% | - | - | |
| May 20, 2020 | CHE Chemed Corp | Director | Sell | 300 | $475.53 | $142,659.00 | -4.3% | - | - | |
| May 11, 2020 | CHE Chemed Corp | Director | Sell | 300 | $441.10 | $132,330.00 | -4.3% | - | - | |
| May 11, 2020 | CHE Chemed Corp | Director | Buy | 49 | $431.60 | $21,148.40 | +0.7% | - | - | |
| Feb 25, 2020 | CHE Chemed Corp | Director | Sell | 300 | $469.49 | $140,847.00 | -4.1% | - | - | |
| Aug 12, 2019 | CHE Chemed Corp | Director | Sell | 400 | $432.87 | $173,147.00 | -5.2% | - | - | |
| Mar 21, 2019 | CHE Chemed Corp | Director | Sell | 400 | $328.56 | $131,424.00 | -5.1% | - | - |